Cost-utility analysis of a supervised exercise program for patients with metastatic breast cancer in the PREFERABLE-EFFECT randomized controlled trial (RCT).
Anouk E. Hiensch(Utrecht University), Anne M. May(Utrecht University), Evelyn M. Monninkhof(Utrecht University), Martijn M. Stuiver(Amsterdam Public Health), Joachim Wiskemann(Heidelberg University), Miriam P. van der Meulen(Utrecht University), Eva M. Zopf(Cabrini Hospital), Aniek E.M. Schouten(Utrecht University), Elżbieta Senkus(Gdańsk Medical University), Martina E. Schmidt(German Cancer Research Center), Yvonne Wengström(Karolinska Institutet), Ander Urruticoechea(Osakidetza), Helene Rundqvist(Karolinska University Hospital), Neil K. Aaronson(The Netherlands Cancer Institute), Karen Steindorf(German Cancer Research Center), Elsken van der Wall(University Medical Center Utrecht), Dorothea Clauss(German Sport University Cologne), Mark Trevaskis(Australian Catholic University), Jana Mueller(Heidelberg University), Wilhelm Bloch(German Sport University Cologne)
Cited by 3
Related Papers
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k